In fulminant hepatic failure the general reduction in protein synthesis by the liver leads to a fall in the plasma concentration of many clotting factors', which is often sufficient to cause spontaneous bleeding. The concentration of clotting factors can sometimes be maintained, and bleeding prevented, by the transfusion of blood or blood products, but even this may be unsuccessful owing to an abnormally rapid loss of the transfused factors. Patients with hepatic coma have a fast clearance of fibrinogen,2 and indirect evidence suggests that platelets and coagulation factors other than fibrinogen are also involved in a process of intravascular coagulation.
whom 75 were in coma. Of 56 patients treated conservatively 13 survived, whereas there were no survivors in the 21 treated by corticosteroids, exchange transfusion, cross circulation, or hyperbaric oxygen. However, it is again quite likely that the more severe cases were treated by the more active measures. In the F.H.F.S. study of 101 patients in whom no treatment procedures were undertaken 10% survived,' while 24% of 166 patients lived in whom exchange transfusions were done.
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Intravascular Coagulation
Many patients with fulminant hepatic failure show mild thrombocytopenia when platelet production is active. At the same time circulating fibrin degradation products are often increased.2 Hence the increased clearance of fibrinogen is probably due to consumption by coagulation in the blood stream. This "disseminated intravascular coagulation," "consumption coagulopathy," or "chronic defibrination," is seen in many states when blood comes into contact with damaged cells.3 In fulminant hepatic failure the stimulus probably comes from blood in contact with damaged liver cells.
Perhaps the most cogent argument in favour of intravascular coagulation, and the importance of its recognition, lies in the fact that heparin given to the patient tends to return fibrinogen clearance to normal. Such intravascular coagulation must throw an extra strain on the already overtaxed production capacity of the liver for clotting proteins. function is given by bile flow and the appearance of an evenly perfused liver surface. This period before connexion to the patient also allows the pH of the perfusate to be adjusted, since this tends to be low owing to the unavoidable slight ischlemia of the liver during hepatectomy.
